1. Introduction
Encapsulation of materials in microparticles dispersed in solution may find application in several fields, such as food chemistry, imaging, energy production and therapeutic/diagnostic medicine [
1]. Examples of microsystems able to encapsulate active ingredients, microsystems including functional polymeric micro- and nanoparticles, core–shell structures, microsponges and microspheres have been developed [
2]. In particular, oil-in-water (O/W) emulsification is a simple, low-cost and effective method for preparing aqueous suspensions of microcapsules filled with oil-soluble active ingredients [
3].
The microcapsule shell prevents the diffusion of the confined compounds out of the core, providing a thick barrier that can also protect sensitive compounds from acidic, alkaline or enzymatic degradation. Moreover, microcapsules may respond to external stimuli such as changes in pH, temperature, light, magnetic and acoustic fields, to enable the timely and spatially controlled release of the encapsulated components [
4]. Microcapsules made from proteins have the advantage of being biocompatible and biodegradable and, for these properties, they have been extensively studied for pharmaceutical and food targeted applications [
5].
Zein (ZP) is the major storage protein of corn (maize), recognized as safe by the Food and Drug Administration [
6]. It has unique amphiphilic and self-assembly properties, it is biodegradable, edible, and it is sourced in large scale from the surpluses of corn and byproducts of the milling and bioethanol industries [
7,
8,
9,
10,
11]. Applications of ZP include use in fibers, adhesives, coating, ceramics, inks, cosmetics, textiles, and biodegradable plastics [
6,
12,
13,
14,
15]. However, ZP insolubility in water and its poor nutritional quality (negative nitrogen balance) limit its use in human food products, while it is primarily used in food packaging and coating [
16]. For instance, ZP is known to form a robust, lustrous, hydrophobic grease-proof coating that can be used as a biodegradable film and plastics, providing resistance to microbial attack [
17].
From the molecular point of view, ZP is encoded in a large multigene family and is constituted by a heterogenous mixture of polypeptides of different molecular sizes, solubility and charge [
18]. Several ZP fractions have been identified, that can be divided into four main fraction, i.e., α-(70-80%), β- (10-20%), γ- and δ-ZP. Presently, more than 60 structures are deposited on the ZP UniProt KB database [
19], and more than 40 for the α-ZP [
20]. α-ZP is divided in α-ZP19 and α-ZP22, of approximate weights of 19 and 22 kDa, respectively; β-ZP contains two 14-15 kDa polypeptides; γ-ZP include two polypeptides of 27 and 16 kDa, respectively; δ-ZP is a minor fraction of the total ZP and has an approximate weight of 10 kDa. [
21,
22] ZP is particularly rich in hydrophobic amino acids (more than 50%), deficient in acidic and basic amino acids, but rich in glutamic acid residues (21-26%), most of which, however, are amidated as glutamines and asparagines.
The high proportion of non-polar amino acids causes the low ZP solubility in water and its prevalent hydrophobic character. ZP is soluble in binary solutions consisting of lower aliphatic alcohols and water, such as 50-90% aqueous ethanol [
23]. It should be stressed, however, that different ZP fractions show different solubility properties. Interestingly, enzymatic modification with alcalase was used to make ZP water soluble [
24].
The secondary structure of ZP was investigated by circular dichroism (CD), and FTIR spectroscopies. It is reported that ZP is characterized by a ~40-60% helical content, complemented by β-sheets (30%) and β-turns (20%) structures [
25,
26,
27]. On the other hand, so far, there is no consensus on the tertiary structure of ZP [
10]. Argos et al. [
28] proposed a ZP 3D model comprising nine adjacent, anti-parallel helices joined by glutamine-rich “turns” or “loops” clustered within a distorted cylinder. The polar and hydrophobic residues distributed along the helical surfaces developed intra- and intermolecular hydrogen bonding, so that ZP could be arranged in planes. It has also been shown that ZP is able to self-assemble into mesophases of different morphology depending on the specific experimental conditions, that can be exploited to modulate the hydrophilic-hydrophobic balance of the system [
29,
30]. In particular, ZP led to the formation of stable nanostructures, such as fibers, nanoparticles, microspheres and thin films [
17].
Emulsification is commonly used as a tool for the confinement of solid, liquid, or gaseous materials in micrometer-sized capsules. Among the methods usually applied for emulsion preparation, ultrasounds have attracted much attention because it is considered as an eco-friendly and cost-effective technique [
2]. Acoustic cavitation is the primary mechanism for the synthesis of microcapsules, achieved by the formation and collapse of microbubbles under ultrasound pressure through multiple in-phase expansion and contraction steps [
3]. In addition, acoustic cavitation can also boost the disruption of oil droplets, facilitating the formation of stable emulsions [
1].
Cavitation effects are highly dependent on the applied ultrasound frequency. The amount of energy released by the bubble collapse and the maximum bubble size before collapse (resonance size) are correlated, and approximately inversely proportional to the applied frequency. Ultrasound parameters such as frequency and acoustic power can be tuned to control the number of cavitation events, the microcapsules size, and their surface roughness and structure [
1]. While the low-frequency ultrasound region (16-100 kHz) gives rise to the formation of larger bubbles followed by intense bubble collapse, resulting in localized shear stress and high local temperatures, the intermediate ultrasound region (100 and 1000 kHz) results in a moderately intense bubble collapse with an efficient radical production in the range between 200 and 500 kHz. Low frequency ultrasounds have already been used to prepare protein microcapsules and microbubbles, stabilized by crosslinked protein shells which can be dispersed in aqueous media [
31]. During the emulsification stage, the bubbles or liquid droplets (the core) act as ‘templates’ for the formation of the protein shells. Reversible protein coatings are stabilized through hydrophobic interactions and/or hydrogen bonding, while irreversible coatings require that covalent linkages, like disulfide bonds, are formed. In the latter case, covalent links can be induced by reactions involving free radicals generated through ultrasonic cavitation [
2,
3,
4].
Herein, the amphiphilic character of ZP was exploited to stabilize the interface of core droplets dispersed in the medium, thus forming a tight and effective protective coating for the encapsulated compounds. The most common methods applied for obtaining ZP nano- and micro-structures are antisolvent precipitation, coacervation/phase separation, evaporation-induced self-assembly, electrospraying and electrospinning, Pickering emulsion [
32,
33]. Although several studies focused on the ZP properties as stabilizer in emulsion formulations, only few studies have reported the production of ZP microcapsules by ultrasound assisted emulsification (UAE).
4. Conclusions
In this work, ZP material was first characterized with the aim to develop an affordable and low-cost method for the synthesis and preparation of protein microcapsules. Next, the properties of the ZP microcapsules synthesized and stored under optimal experimental conditions, were characterized focusing on their stability over time and after drying and thermal shocking. Finally, as a proof-of-principle experiment, the ability of ZP microcapsules to encapsulate Curcumin, was tested and confirmed.
Due to the ZP solubility properties, a binary mixture of EtOH/H2O 70/30 (v/v) was chosen as solvent and used for the spectroscopic measurements. The ZP secondary structure was extrapolated by deconvolution of the far-UV CD signal, providing results in agreement with literature data and consistent with PDB previsions. It has been shown that proteins with an α-helical content higher than 40%, tend to form β-structures during the aggregation process, passing through coiled-coil intermediate structures, and that the formation of ZP aggregates is favored by an increment of β-sheet structures [
39]. It should be noted that the reversibility of the ZP thermal-induced modifications is controversial in literature, as earlier studies support the formation of ZP oligomers and protein ordered arrangements during the thermal treatment [
64].
CD data support this scenario, as they displayed a partial structural reorganization from α to β structure, together with the increase of random coil conformations at increasing temperatures. Moreover, quenching of the fluorescence emission intensity is typical of aggregation phenomena. However, aggregation should have also caused increased contribution of scattered light, which has not been detected.
ZP microcapsules were formed by UAE of O/W solutions, producing oil droplets coated by a protein shell, as the result of the emulsification process and the ZP amphiphilic properties. ZP microcapsule size and density were determined by the concomitant effect of the applied ultrasound acoustic power, sonication times, protein concentration and temperature. In particular, the protein concentration turned out to be the most influential parameter, as regard the particle density and size, while the applied acoustic power and sonication time mainly affect the microcapsule structure and integrity over time. This is because the acoustic power is related to shear forces, that are fundamental in the assembly of the protein units at the interface of the oil droplets [
2].
Combining all the available information from the DOE analysis, the following experimental conditions should be considered as the parameters of choice: O/W emulsion with 1:100 oil/solution (v/v) ratio, 20 kHz sonication frequency, 10 mg/mL ZP concentration in EtOH/H2O 70/30 (v/v) solution, 220 W acoustic power, 25 s sonication time in an ice bath. Under these experimental conditions ZP microcapsules with diameters of 0.9 ± 0.3 μm, showing minimum coalescence and particle density drop over long times, were obtained.
The ZP microcapsule morphology was characterized by FE-ESEM and CLSM imaging, providing evidence of an oil-filled inner phase stabilized by a ZP outer shell coating. Noteworthy, the oil core is preserved when coalescence occurs, resulting in larger oil-filled microcapsules. Dispersibility and stability in water of dried ZP microcapsules have also been studied, finding that, although ZP is not soluble in water, ZP microcapsules can be successfully transferred and stored in an aqueous environment, as H2O/EtOH 90/10 (v/v) or even pure water, a crucial result in view of future applications.
ZP microcapsules in EtOH/H2O 70/30 (v/v), H2O/EtOH 90/10 (v/v) and H2O were exposed to different temperatures (25 – 75°C) to study their thermal stability. Responses to temperature varied between the different samples, but ZP microcapsules were not disrupted by the thermal treatment.
Proof-of-principle studies on the inclusion of an active ingredient into ZP microcapsules were also carried out using Curcumin, a fluorescent molecule showing unique pharmaceutical and nutraceutical properties. Unfortunately, its utilization in food and supplement products is still limited because of its extremely low (3×10
-8 M) water solubility, poor chemical stability, and low oral bioavailability. These drawbacks make Curcumin difficult to incorporate into many products and to be solubilized in the aqueous fluids within the gastrointestinal tract. Moreover, a major factor that limits Curcumin bioavailability is its rapid degradation by hydrolysis and chemical instability under physiological conditions. It has already been shown that solubility, stability and bioavailability of Curcumin can be strongly enhanced by encapsulation [
65].
The established microencapsulation protocol proved to be successful, and Curcumin, was efficiently included and retained in the ZP microcapsules. These results set a promising ground for future studies on the subject, considering the existing barriers to ZP transfer and delivery, passing through the stomach and the gastrointestinal tract [
66]. In vitro and in vivo studies concerning the capacity of ZP microcapsules to preserve the encapsulated Curcumin, and allow for its controlled spatial and temporal release will be the object of future investigation.
Figure 1.
Far-UV circular dichroism spectrum of 0.3 mg/mL ZP in EtOH/H2O 70/30 (v/v) at different temperatures. Black: 15°C, red: 25°C, blue: 35°C, magenta: 45°C, green: 55 °C, dark blue: 65°C, purple: 75°C.
Figure 1.
Far-UV circular dichroism spectrum of 0.3 mg/mL ZP in EtOH/H2O 70/30 (v/v) at different temperatures. Black: 15°C, red: 25°C, blue: 35°C, magenta: 45°C, green: 55 °C, dark blue: 65°C, purple: 75°C.
Figure 2.
Fluorescence emission and excitation spectra of 0.3 mg/mL Zein in EtOH/H2O 70/30 (v/v) at 25 °C. A) Dashed line: excitation spectrum of tyrosine (λem=308 nm); solid line: emission spectrum of tyrosine(λexc=278 nm). B) Dashed line: excitation spectrum of dityrosine (λem=420 nm); solid line: emission spectrum of dityrosine, (λexc=320 nm).
Figure 2.
Fluorescence emission and excitation spectra of 0.3 mg/mL Zein in EtOH/H2O 70/30 (v/v) at 25 °C. A) Dashed line: excitation spectrum of tyrosine (λem=308 nm); solid line: emission spectrum of tyrosine(λexc=278 nm). B) Dashed line: excitation spectrum of dityrosine (λem=420 nm); solid line: emission spectrum of dityrosine, (λexc=320 nm).
Figure 3.
Optical microscopy images of O/W emulsions from EtOH/H2O 70/30 (v/v) ZP solutions and 50 µL SO. A: 2.5 mg/mL ZP, t=0; B: 5 mg/mL ZP, t=0; C: 2.5 mg/mL ZP, t = 4 days; D: 5 mg/mL ZP, t = 4 days. Scale bar: 20 μm.
Figure 3.
Optical microscopy images of O/W emulsions from EtOH/H2O 70/30 (v/v) ZP solutions and 50 µL SO. A: 2.5 mg/mL ZP, t=0; B: 5 mg/mL ZP, t=0; C: 2.5 mg/mL ZP, t = 4 days; D: 5 mg/mL ZP, t = 4 days. Scale bar: 20 μm.
Figure 4.
Bright-field (A) and fluorescence (B) microscopy images of O/W emulsion prepared by UAE of 5.0 mg/mL ZP EtOH/H2O 70/30 (v/v) solution and 10 µL SO. NLR has been included in SO before the microcapsule preparation. Sample volume: 1mL; frequency: 20 kHz, power: 220 W, UAE in continuous mode. Scale bar: 10 μm.
Figure 4.
Bright-field (A) and fluorescence (B) microscopy images of O/W emulsion prepared by UAE of 5.0 mg/mL ZP EtOH/H2O 70/30 (v/v) solution and 10 µL SO. NLR has been included in SO before the microcapsule preparation. Sample volume: 1mL; frequency: 20 kHz, power: 220 W, UAE in continuous mode. Scale bar: 10 μm.
Figure 5.
Bright-field (A, C) and fluorescence (B, D) microscopy images of O/W emulsions formed by 5.0 mg/mL ZP in EtOH/H2O 70/30 (v/v) and 10 µL SO solution. NLR has been included in SO before the synthesis. Particle clusters are imaged after +4 days from the synthesis. Sample volume: 1mL; frequency: 20 kHz, power: 220 W, UAE in continuous mode. Scale bar: 20 μm.
Figure 5.
Bright-field (A, C) and fluorescence (B, D) microscopy images of O/W emulsions formed by 5.0 mg/mL ZP in EtOH/H2O 70/30 (v/v) and 10 µL SO solution. NLR has been included in SO before the synthesis. Particle clusters are imaged after +4 days from the synthesis. Sample volume: 1mL; frequency: 20 kHz, power: 220 W, UAE in continuous mode. Scale bar: 20 μm.
Figure 6.
3D confocal microscopy image of O/W emulsions from 10 mg/mL ZP EtOH/H2O 70/30 (v/v) and 10 mL SO solution. A: NLR added to the oil phase before the synthesis. B: RhB added to the aqueous solution before the synthesis. Sample volume: 1mL. Synthesis conditions: power= 220 W, time = 25 s; frequency:20 kHz, UAE in continuous mode, test tube in ice bath.
Figure 6.
3D confocal microscopy image of O/W emulsions from 10 mg/mL ZP EtOH/H2O 70/30 (v/v) and 10 mL SO solution. A: NLR added to the oil phase before the synthesis. B: RhB added to the aqueous solution before the synthesis. Sample volume: 1mL. Synthesis conditions: power= 220 W, time = 25 s; frequency:20 kHz, UAE in continuous mode, test tube in ice bath.
Figure 7.
SEM images of O/W emulsions from 10 mg/ml Zein EtOH/H2O 70/30 (v/v) and 10 ml SO solutions, A: day of synthesis. B: after 18 days. Synthesis conditions: power= 220 W, time= 25 s, frequency= 20 kHz, UAE in continuos mode.
Figure 7.
SEM images of O/W emulsions from 10 mg/ml Zein EtOH/H2O 70/30 (v/v) and 10 ml SO solutions, A: day of synthesis. B: after 18 days. Synthesis conditions: power= 220 W, time= 25 s, frequency= 20 kHz, UAE in continuos mode.
Figure 8.
Bright field optical (A) and fluorescence (B) microscopy images of Zein microcapsule encapsulating Curcumin. Curcumin has been included in SO before the microcapsule synthesis. Scale bar: 20 μm.
Figure 8.
Bright field optical (A) and fluorescence (B) microscopy images of Zein microcapsule encapsulating Curcumin. Curcumin has been included in SO before the microcapsule synthesis. Scale bar: 20 μm.
Table 1.
Secondary structure for αZP-22KDa, αZP-22KDa and ZP from CD experiments (T=25°C).
Table 1.
Secondary structure for αZP-22KDa, αZP-22KDa and ZP from CD experiments (T=25°C).
Secondary 刘structure |
ZP (fresh)刘(%) |
ZP (1 day)刘(%) |
ZP (10 days)刘(%) |
ZP*刘(%) |
α-helix |
48.6 |
45.0 |
45.8 |
56.7 |
antiparallel β-sheet |
6.1 |
0.8 |
1.2 |
7.1 |
turns |
13.9 |
13.3 |
13.4 |
8.2 |
random coil |
31.3 |
40.9 |
39.7 |
28.0 |